Monitoring Agency Report for the quarter ended December 31, 2025
AYMSYNTEX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
AYM Syntex has fully utilized the Rs. 141.76 crore raised through a preferential issue of equity shares allotted on December 18, 2024. During the quarter ended December 31, 2025, the company deployed the remaining Rs. 4.43 crore toward capital expenditure, completing the use of all issue proceeds. The funds were used for four stated purposes: repayment of debt (Rs. 24 crore), reduction of working capital borrowings (Rs. 25 crore), general corporate purposes (Rs. 33.76 crore), and capital expenditure (Rs. 59 crore). CARE Ratings, the Monitoring Agency, reported zero deviation from the disclosed objects. The company also mentioned planned capacity expansion for IDY and BCF segments at a total cost of Rs. 100 crore, expected to be completed in 1-1.5 years.
This is a routine compliance filing confirming disciplined and complete use of the preferential issue proceeds exactly as promised to investors. It signals good governance and no misuse of funds, which is mildly positive for shareholder confidence but unlikely to move the stock price on its own.